WJET Erie on MSN2mon
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billionor GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed ...
GSK has reached ... 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle ...
GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...
Pfizer has agreed to settle more than 10,000 lawsuits which alleged that ... in the summer of 2022 after concerns about ...
To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit settlement, please visit the company's website HERE or call 877.571.0405. Settlement monies are not expected ...
GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.
GSK’s shares ... slightly lower after it agreed a $2.2 billion settlement over lawsuits in the US, which alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer.
GSK last month agreed to settle about 80,000 Zantac lawsuits, representing most of the litigation against it, for $2.2 billion. Pfizer has also agreed to settle most of the outstanding cases ...
Operating profit fell by 86 per cent, and earnings per share slumped due to a settlement charge of £1.8bn related to the Zantac lawsuits. The lawsuits arose after recipients of GSK’s heartburn drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback